Particle.news
Download on the App Store

Remedy CEO Tero Virtala Steps Down as Co-Founder Markus Mäki Becomes Interim Chief

The move follows a profit outlook cut after weak sales of FBC: Firebreak.

Overview

  • Virtala leaves the top job with immediate effect and will stay for an agreed transition while the company begins its search for a new leader.
  • Co-founder and chief product officer Markus Mäki assumes the interim CEO role on October 22, as board member Henri Österlund becomes chairman.
  • Remedy recorded a €14.9 million non-cash impairment tied to FBC: Firebreak’s capitalized development costs and purchased publishing and distribution rights.
  • The company now expects 2025 operating profit to decrease compared with its earlier forecast.
  • The announcement did not give a reason for the change, though some coverage links it to Firebreak’s underperformance, and fuller details are due with the Q3 2025 Business Review on October 29.